Skip to main content

Partnerships: Industry & Academic

Engaging Industry and Academic Partners

CCTG is know for cancer clinical trial research and is the world's largest cooperative collaborative oncology group. Our success is realized through our network of investigators who develop scientifically important and meaningful trials, conducted both rapidly and to rigorous standards. With over 40 years of experience there is no network that rivals the depth and breadth of operations with a global reputation for rapid execution of quality clinical trials.

Partnerships

National and international collaboration

Industry partnerships

While CCTG trials are independently conducted, analyzed and reported. Pharmaceutical or academic drug manufacturers provide CCTG access to their investigational new drugs because they recognize the high quality research being conducted through the group.

 

EN12 RAINBO-ORANGE successful CIHR Project Grant funding

EN12 RAINBO-ORANGE successful CIHR Project Grant funding

The EN12 RAINBO-ORANGE clinical trial was awarded $1,575,898 through the CIHR Project Grant to investigate if surgery followed by radiotherapy and a type of oral endocrine therapy called progestins will lead to similar cancer control as surgery followed by radiotherapy and chemotherapy in patients with NSMP, estrogen receptor-positive endometrial cancer (EC).

More >>
 
The first two CCTG led cell therapy trials are now open in Canada

The first two CCTG led cell therapy trials are now open in Canada

CCTG is committed to the evaluation of innovative cell therapy products, strategies to improve cell therapy outcomes and to advancing accessibility for Canadian patients. IND246 study is a phase I trial evaluating increasing dose levels of GCAR1 and IND245 is a trial evaluating the addition of sonrotoclax and zanubrutinib in patients with mantle cell lymphoma.

More >>
 
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer

CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer

CCTG, EORTC and UK3CR welcome the G7 Leaders’ announcement recognizing cancer as a global priority.

More >>
 
Drs. Raphael, Maleki, and Silverman

Largest-ever Canadian clinical trial tests “poop pills” to improve immunotherapy for lung cancer

For nearly half of people diagnosed with lung cancer, immunotherapy can slow the disease but not stop it. Funded through a $4 million joint investment from the Canadian Cancer Society (CCS) and the Weston Family Foundation, a new clinical trial aims to change that.

More >>